You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Locally%20Advanced

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Gastric Cancer Trial in Shanghai (sintilimab+metronomic PLOF)

Recruiting
  • Gastric Cancer
  • sintilimab+metronomic PLOF
  • Shanghai, China
    Huashan Hospital, Fudan University
Sep 22, 2023

Immunotherapy in Advanced or Locally Advanced dMMR/MSI-H

Recruiting
  • Colorectal Cancer
    • Shanghai, China
      Fudan University Shanghai Cancer Center
    Oct 18, 2023

    Recurrent Vulvar Cancer, Persistent Vulvar Cancer, Metastatic Vulva Cancer Trial (Pembrolizumab, Lenvatinib)

    Not yet recruiting
    • Recurrent Vulvar Cancer
    • +3 more
    • (no location specified)
    Jun 12, 2023

    Thymic Carcinoma Trial in Shanghai (Envolizumab combined with radiotherapy)

    Recruiting
    • Thymic Carcinoma
    • Envolizumab combined with radiotherapy
    • Shanghai, Shanghai, China
      Shanghai Pulmonary Hospital
    Sep 3, 2023

    Differentiated Thyroid Cancer Trial in Shanghai (surufatinib)

    Recruiting
    • Differentiated Thyroid Cancer
    • Shanghai, Shanghai, China
      Fudan University Shanghai Cancer Center
    Aug 9, 2023

    Cervical Cancer, Induction Chemo, Immunotherapy Trial in Tianjin (Toripalimab)

    Recruiting
    • Cervical Cancer
    • +2 more
    • Tianjin, Tianjin, China
      Tianjin Medical University Cancer Institute & Hospital
    Oct 16, 2023

    Rectal Cancer Trial (CapeOX + cetuximab, CapeOX + bevacizumab, radiotherapy)

    Not yet recruiting
    • Rectal Cancer
    • CapeOX + cetuximab
    • +2 more
    • (no location specified)
    Sep 12, 2023

    Neoadjuvant Envafolimab in Resectable and Locally Advanced

    Not yet recruiting
    • Locally Advanced Rectal Carcinoma
    • MSI-High
    • (no location specified)
    Dec 9, 2022

    Contribution of PET/MRI in Locally Advanced Cervical Cancer

    Not yet recruiting
    • Cervical Cancer
    • 18-FDG PET-MRI
    • Strasbourg, France
      Institut de cancérologie Strasbourg Europe
    Oct 12, 2023

    Pancreas Adenocarcinoma, Borderline Resectable Pancreatic Adenocarcinoma, Locally Advanced Pancreatic Adenocarcinoma Trial in

    Not yet recruiting
    • Pancreas Adenocarcinoma
    • +2 more
    • Nab paclitaxel
    • +3 more
    • Winston-Salem, North Carolina
      Wake Forest Baptist Comprehensive Cancer Center
    Apr 19, 2023

    Colon Cancer, Immunotherapy Trial in Chongqing (Terelizumab, CapeOx)

    Not yet recruiting
    • Colon Cancer
    • Immunotherapy
    • Chongqing, China
      Daping hospital
    Apr 16, 2023

    Locally Advanced Nasopharyngeal Carcinoma Trial in Guangzhou (2 cycles induction chemo, 3 cycles induction chemo)

    Recruiting
    • Locally Advanced Nasopharyngeal Carcinoma
    • 2 cycles induction chemotherapy
    • 3 cycles induction chemotherapy
    • Guangzhou, Other (Non U.s.), China
      First Affiliated Hospital, Sun Yat-Sen University
    May 6, 2023

    Locally Advanced Solid Tumors, Recurrent Solid Tumors, Metastatic Solid Tumors Trial (RO7566802, Atezolizumab)

    Not yet recruiting
    • Locally Advanced Solid Tumors
    • +2 more
    • (no location specified)
    Sep 4, 2023

    GENE EXPRESSION PROFILING IN A VALIDATION COHORT OF LOCALLY

    Not yet recruiting
    • Salivary Gland Cancer
    • Observation
    • (no location specified)
    Oct 13, 2023

    Solid Tumors Trial (IBR854 Cell Injection)

    Not yet recruiting
    • Solid Tumors
    • IBR854 Cell Injection
    • (no location specified)
    Aug 14, 2023

    Locally Advanced Rectal Cancer Trial in Beijing (capecitabine, tislelizumab, thymalfasin)

    Not yet recruiting
    • Locally Advanced Rectal Cancer
    • Beijing, China
    • +1 more
    Sep 21, 2023

    Pulmonary Tumor, Advanced Cancer, Locally Advanced Cancer Trial in Shanghai (Surgery)

    Recruiting
    • Pulmonary Neoplasm
    • +2 more
    • Surgery
    • Shanghai, Shanghai, China
      Ruijin hospital, Shanghai JiaoTong University School of Medicine
    Dec 15, 2022

    Nab-paclitaxel Plus Gemcitabine-cisplatin Chemotherapy in

    Not yet recruiting
    • Locally Advanced Cholangiocarcinoma
      • Seongnam-si, Gyeonggi-do, Korea, Republic of
        CHA Bundang Medical Center
      Jan 24, 2023

      Plasma MRD and cfDNA HPV and Efficacy and Prognosis of Locally

      Recruiting
      • Locally Advanced Cervical Cancer
      • Concurrent chemoradiotherapy
      • Guiyang, Guizhou, China
        Yong Li
      Jul 14, 2023

      Neoadjuvant Chemoimmunotherapy in Resectable Locally Advanced

      Completed
      • Oral Cancer
      • PD-1 inhibitor+carboplatin+albumin-bound paclitaxel
      • Guangzhou, Guangdong, China
        Sun Yat-Sen Memorial Hospital
      Nov 20, 2023

      Locally Advanced, High-Risk, Rectal Cancer Trial in Guangzhou (Toripalimab, short-term radiotherapy, Oxaliplatin)

      Not yet recruiting
      • Locally Advanced
      • +3 more
      • Guangzhou, Guangdong, China
        Nanfang Hospital Southern Medical University
      May 17, 2023

      Locally Advanced Esophageal Squamous Cell Carcinoma Trial (Tiragolumab)

      Not yet recruiting
      • Locally Advanced Esophageal Squamous Cell Carcinoma
      • (no location specified)
      Feb 23, 2023

      Metastatic Breast Cancer, Locally Advanced Breast Cancer, Breast Cancer Trial in Ocala (Samuraciclib, Fulvestrant)

      Recruiting
      • Metastatic Breast Cancer
      • +2 more
      • Ocala, Florida
        Ocala Oncology Center PL DBA Florida Cancer Affiliates
      Jul 19, 2023

      Locally Advanced Breast Cancer Trial in Beijing (Modified radical mastectomy for breast cancer, neoadjuvant therapy, Systematic

      Recruiting
      • Locally Advanced Breast Cancer
      • Modified radical mastectomy for breast cancer
      • +2 more
      • Beijing, China
        Ying Xu
      Oct 6, 2023

      Advanced or Unresectable Locally Advanced Bone and Soft Tissue Sarcoma Trial (fruquintinib, Envafolimab)

      Not yet recruiting
      • Advanced or Unresectable Locally Advanced Bone and Soft Tissue Sarcoma
      • (no location specified)
      Jul 10, 2023